Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tongzhi Surunjiang Tablet
- Development stage
- Preclinical
- Lead developer
- Xinjiang Uygur Pharmaceutical
- Administration
- Oral
01
Overview
Tongzhi Surunjiang Tablet is a traditional Uighur herbal medicine developed by Xinjiang Uighur Pharmaceutical Co., Ltd. for the treatment of rheumatism and joint pain, particularly acute gouty arthritis. The formulation consists of several herbal ingredients, including Senna, Colchicum, Terminalia chebula, box fruit vine, almond, saffron, and scabra. Pharmacological studies indicate that the drug effectively relieves symptoms by reducing inflammatory markers such as erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP), and by suppressing the expression of pro-inflammatory cytokines including Interleukin-1 beta (IL-1β) and Tumor Necrosis Factor-alpha (TNF-α). While a capsule version of this formulation is already a National Medical Insurance product in China, the tablet formulation is currently in the IND-enabling/clinical approval phase.
- Brand names
- Tongzhi Surunjiang
- Other names
- 通滞苏润江片Tongzhisurunjiang Tablet
02
Targets
IL1B (Interleukin-1 beta)NLRP3 (Nod-like receptor family pyrin domain-containing protein 3)TNFA (Tumor necrosis factor alpha (soluble))
Beyond the preview
Go deeper on Tongzhi Surunjiang Tablet.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tongzhi Surunjiang Tablet.